Literature DB >> 10705187

The EMCDDA/Pompidou Group treatment demand indicator protocol: a European core item set for treatment monitoring and reporting.

R Simon1, M Donmall, R Hartnoll, A Kokkevi, A W Ouwehand, M Stauffacher, J Vicente.   

Abstract

Over the last decades inside and outside of Europe, treatment-based data have been used in epidemiological research on drugs and drug abuse. They offer information on hidden populations and allow to follow socially stigmatised behaviour. As this type of research can be done on rather low budgets, there are long-term projects run in many countries. Experts from the national systems in several EU member states have been working together to develop a common standard on the basis of the Pompidou Group (PG) Definitive Protocol. The items and basic definitions of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)/PG Treatment Demand Indicator Protocol are described, which plays an important role in the process of harmonisation of data collection for the EMCDDA. Implementation strategies are described, and future steps are discussed. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10705187     DOI: 10.1159/000018994

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  9 in total

1.  Examining the Relationship of Personality Functioning and Treatment Completion in Substance Misuse Treatment.

Authors:  Fivos E Papamalis
Journal:  Subst Abuse       Date:  2020-10-06

2.  General practice patients treated for substance use problems: a cross-national observational study in Belgium.

Authors:  Nicole Boffin; Jerome Antoine; Sarah Moreels; Simeon Wanyama; Karin De Ridder; Lieve Peremans; Marc Vanmeerbeek; Viviane Van Casteren
Journal:  BMC Public Health       Date:  2016-12-08       Impact factor: 3.295

3.  Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study.

Authors:  Ifeoma N Onyeka; Caryl M Beynon; Hanna Uosukainen; Maarit Jaana Korhonen; Jenni Ilomäki; J Simon Bell; Mika Paasolainen; Niko Tasa; Jari Tiihonen; Jussi Kauhanen
Journal:  BMC Public Health       Date:  2013-04-23       Impact factor: 3.295

4.  Cocaine treatment admissions at three sentinel sites in South Africa (1997-2006): findings and implications for policy, practice and research.

Authors:  Charles D H Parry; Andreas Plüddemann; Bronwyn J Myers
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-12-28

5.  Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.

Authors:  Jérôme Antoine; Karin De Ridder; Els Plettinckx; Peter Blanckaert; Lies Gremeaux
Journal:  Arch Public Health       Date:  2016-07-01

6.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22

Review 7.  Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand.

Authors:  Alison Ritter; Richard Mellor; Jenny Chalmers; Matthew Sunderland; Kari Lancaster
Journal:  J Stud Alcohol Drugs Suppl       Date:  2019-01

8.  The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.

Authors:  Linda Montanari; Alessandro Pirona; Bruno Guarita; Dagmar Hedrich; Jane Mounteney; Julian Vicente
Journal:  J Stud Alcohol Drugs Suppl       Date:  2019-01

9.  HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates.

Authors:  Anastasios Fotiou; Eleftheria Kanavou; Argyro Antaraki; Clive Richardson; Manina Terzidou; Anna Kokkevi
Journal:  Hepatol Med Policy       Date:  2016-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.